𝔖 Bobbio Scriptorium

✦ LIBER ✦

PIN6: ESTIMATED COSTS TO CONDUCT A PHASE III CLINICAL TRIAL OF A NEW PULMONARY TUBERCULOSIS DRUG

✍ Scribed by M Dombeck; SL Dennett; CD Hamilton; L Bell

Book ID: 118613833
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 68 KB
Volume: 4
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71585-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New perspective on the nutritional appro

New perspective on the nutritional approach to cancer-related anorexia/cachexia: preliminary results of a randomised phase III clinical trial with five different arms of treatment

✍ Francesca Maria Tanca; Clelia Madeddu; Antonio Macciò; Roberto Serpe; Filomena P 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 139 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB